Dry age-related macular degeneration (AMD) is a leading cause of vision loss in individuals over 50. The condition affects the central vision and can range from mild to severe stages. DelveInsight’s report provides a comprehensive understanding of the current treatment landscape, market size, and emerging therapies for dry AMD.